Showing results (1771-1780 of 1,907) with videos related to
Sort By:
Pageof 191
Neurology. Genetics|April 29, 2016
Paroxysmal hypnogenic dyskinesia is associated with mutations in the PRRT2 geneXiao-Rong Liu, Dan Huang, Jie Wang, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|April 12, 2012
G-protein-coupled receptor 30 mediates rapid neuroprotective effects of estrogen via depression of NR2B-containing NMDA receptorsShui-bing Liu, Nan Zhang, Yan-yan Guo, et al.Journal of Cellular Biochemistry|August 11, 2017
Effects of long noncoding RNA SPRY4-IT1-mediated EZH2 on the invasion and migration of lung adenocarcinomaXin Wen, Xin-Rui Han, Yong-Jian Wang, et al.Insect Science|March 27, 2019
Clathrin-dependent endocytosis predominantly mediates protein absorption by fat body from the hemolymph in Bombyx moriYu-Jie Wang, Shu-Yan Li, Jia-Ye Zhao, et al.Molecular Medicine (Cambridge, Mass.)|June 20, 2019
FBXW7 suppresses HMGB1-mediated innate immune signaling to attenuate hepatic inflammation and insulin resistance in a mouse model of nonalcoholic fatty liver diseaseCheng Zhang, Feng Chen, Li Feng, et al.Bioorganic & Medicinal Chemistry|November 24, 2005
Design, synthesis, and SAR analysis of cytotoxic sinapyl alcohol derivativesHong Bin Zou, Sheng Yi Dong, Chang Xin Zhou, et al.Journal of Cellular Physiology|February 22, 2019
Retracted: The role of HOTAIR-induced downregulation of microRNA-126 and interleukin-13 in the development of bronchial hyperresponsiveness in neonatesDong-Mei Wu, Zi-Hui Zheng, Shan Wang, et al.Nature Communications|April 7, 2021
Creating polar antivortex in PbTiO3/SrTiO3 superlatticeAdeel Y Abid, Yuanwei Sun, Xu Hou, et al.Metabolites|February 25, 2023
Projections from the Rostral Zona Incerta to the Thalamic Paraventricular Nucleus Mediate Nociceptive Neurotransmission in MiceFeng-Ling Wu, Si-Hai Chen, Jia-Ni Li, et al.Annals of Internal Medicine|December 3, 2002
Significant differential effects of alendronate, estrogen, or combination therapy on the rate of bone loss after discontinuation of treatment of postmenopausal osteoporosis. A randomized, double-blind, placebo-controlled trialSusan L Greenspan, Ronald D Emkey, Henry G Bone, et al.Pageof 191